Accounts in drug discovery [electronic resource] : case studies in medicinal chemistry / [edited by] Joel Barrish, Percy Carter, Robert Zahler.

Accounts in Drug Discovery describes recent case studies in medicinal chemistry with a particular emphasis on how the inevitable problems that arise during any project can be surmounted or overcome. The Editors cover a wide range of therapeutic areas and medicinal chemistry strategies, including lea...

Full description

Saved in:
Bibliographic Details
Online Access: Full Text (via RSC)
Other Authors: Barrish, Joel Charles, 1957-, Carter, Percy, Zahler, Robert
Format: Electronic eBook
Language:English
Published: Cambridge : Royal Society of Chemistry, [2010], ©2011.
Series:RSC drug discovery series ; 4.
Subjects:

MARC

LEADER 00000cam a2200000xa 4500
001 b12159193
003 CoU
005 20250117033837.5
006 m o d
007 cr |||||||||||
008 100621t20102011enk o 000 0 eng d
019 |a 904191583 
020 |a 9781849731980  |q (electronic bk.) 
020 |a 1849731985  |q (electronic bk.) 
020 |z 9781849731263 
020 |z 1849731268 
024 7 |a 10.1039/9781849731980 
035 |a (OCoLC)rsc642690086 
035 |a (OCoLC)642690086  |z (OCoLC)904191583 
037 |a rsc9781849731980 
040 |a UKRSC  |b eng  |e pn  |c UKRSC  |d CUS  |d OCLCQ  |d E7B  |d YDXCP  |d N$T  |d MHW  |d OCLCF  |d AZU  |d OCLCQ  |d AGLDB  |d DEBSZ  |d OCLCQ  |d VTS  |d NLE  |d STF  |d LEAUB  |d M8D  |d OCLCQ  |d AJS  |d OCLCQ  |d OCLCO  |d OCLCQ 
049 |a GWRE 
050 4 |a RM301.25  |b .A23 2010 
245 0 0 |a Accounts in drug discovery  |h [electronic resource] :  |b case studies in medicinal chemistry /  |c [edited by] Joel Barrish, Percy Carter, Robert Zahler. 
260 |a Cambridge :  |b Royal Society of Chemistry,  |c [2010], ©2011. 
300 |a 1 online resource. 
336 |a text  |b txt  |2 rdacontent. 
337 |a computer  |b c  |2 rdamedia. 
338 |a online resource  |b cr  |2 rdacarrier. 
490 1 |a RSC Drug Discovery ;  |v 4. 
505 0 0 |t The discovery of the dipeptidyl peptidase-4 (DPP4) inhibitor Onglyza :  |t from concept to market /  |r Jeffrey A. Robl and Lawrence G. Hamann --  |t The discovery of Vorapaxar (SCH 530348), a thrombin receptor (protease activated receptor-1) antagonist with potent antiplatelet effects /  |r Samuel Chackalamannil --  |t The discovery of Piragliatin, a glucokinase activator /  |r Ramakanth Sarabu, Jefferson W. Tilley and Joseph Grimsby --  |t The discovery of OSI-906, a small-molecule inhibitor of the insulin-like growth factor-1 and insulin receptors /  |r Mark J. Mulvihill and Elizabeth Buck --  |t The genesis of the antibody conjugate gemtuzumab ozogamicin (Mylotarg®) for acute myeloid leukemia /  |r Philip R. Hamann --  |t Novel androgen receptor antagonists for the treatment of prostate cancer /  |r Ashvinikumar V. Gavai, William R. Foster, Aaron Balog and Gregory D. Vite --  |t The discovery of UK-390957 :  |t the challenge of targeting a short half-life, rapid Tmax SSRI /  |r Mark D. Andrews and Donald S. Middleton --  |t The discovery of the long-acting PDE5 inhibitor PF-489791 for the treatment of pulmonary hypertension /  |r Andrew S. Bell and Michael J. Palmer --  |t From HTS to market :  |t the discovery and development of maraviroc, a CCR5 antagonist for the treatment of HIV /  |r Chris Barber and David Pryde --  |t The discovery of GS-9131, an amidate prodrug of a novel nucleoside phosphate HIV reverse transcriptase inhibitor /  |r Richard Mackman --  |t 2'-F-2'-C-methyl nucleosides and nucleotides for the treatment of hepatitis C virus :  |t from discovery to the clinic /  |r Michael J. Sofia, Phillip A. furman and William T. Symonds --  |t A case history on the challenges of central nervous system and dual pharmacology drug discovery /  |r Paul V. Fish, Anthony Harrison, Florian Wakenhut and Gavin A. Whitlock --  |t The discovery of TRPV1 antagonists :  |t turning up the heat /  |r Mark H. Norman --  |t Uncoupling neuroprotection from immunosuppression :  |t the discovery of ILS-920 /  |r Edmund I. Graziani --  |t Identification of [alpha] 7 nicotinic acetylcholine receptor agonists for their assessment in improving cognition in schizophrenia /  |r Bruce N. Rogers [and others] 
520 |a Accounts in Drug Discovery describes recent case studies in medicinal chemistry with a particular emphasis on how the inevitable problems that arise during any project can be surmounted or overcome. The Editors cover a wide range of therapeutic areas and medicinal chemistry strategies, including lead optimization starting from high throughput screening ""hits"" as well as rational, structure-based design. The chapters include ""follow-ons"" and ""next generation"" compounds that aim to improve upon first generation agents. This volume surveys the range of challenges commonly faced by medicinal. 
588 0 |a Online resource; title from title screen (viewed on June 15, 2010) 
650 0 |a Drug development  |v Case studies. 
650 0 |a Pharmaceutical chemistry  |v Case studies. 
650 7 |a Drug development.  |2 fast  |0 fst00898670 
650 7 |a Pharmaceutical chemistry.  |2 fast  |0 fst01060115 
655 7 |a Case studies.  |2 fast  |0 fst01423765 
700 1 |a Barrish, Joel Charles,  |d 1957-  |0 http://id.loc.gov/authorities/names/n85809901  |1 http://isni.org/isni/0000000028720502. 
700 1 |a Carter, Percy.  |0 http://id.loc.gov/authorities/names/n91023505 
700 1 |a Zahler, Robert. 
776 0 8 |i Print version:  |t Accounts in drug discovery.  |d Cambridge : Royal Society of Chemistry, [2010], ©2011  |z 9781849731263  |z 1849731268  |w (OCoLC)671469689. 
856 4 0 |u https://colorado.idm.oclc.org/login?url=https://doi.org/10.1039/9781849731980  |z Full Text (via RSC) 
830 0 |a RSC drug discovery series ;  |v 4.  |0 http://id.loc.gov/authorities/names/no2010092643 
907 |a .b121591931  |b 05-03-22  |c 04-19-22 
915 |a - 
998 |a web  |b 04-29-22  |c b  |d b   |e -  |f eng  |g enk  |h 0  |i 1 
907 |a .b121591931  |b 05-02-22  |c 04-19-22 
944 |a MARS - RDA ENRICHED 
956 |a RSC eBooks 
956 |b RSC eBooks 2010 
999 f f |i 28573263-1311-5caf-895b-5505f5d1c5ff  |s 06d392b0-a8c5-5dc2-9cbf-e876475a6d16 
952 f f |p Can circulate  |a University of Colorado Boulder  |b Online  |c Online  |d Online  |e RM301.25 .A23 2010  |h Library of Congress classification  |i web  |n 1